Bloodproducts and Parvovirus B19 - horizon scanning report

Infections with Parvovirus B19 (henceforth referred to as B19) are quite common, particularly in children. The most widespread clinical picture caused by B19 is erythema infectiosum, which is also known as ‘fifth disease’. In otherwise healthy individuals, the infection generally runs its course without serious problems. In some groups, however, such as pregnant women, patients with underlying haematological problems and patients with immunodeficiency, B19 infections can result in serious complications or health problems.

Committee

Blood Working Group

• Dr J van der Noordaa, Emeritus Professor of Virology, Weesp, Chairman
• Dr WG van Aken, Emeritus Professor of Internal Medicine, Amstelveen
• Dr A Brand, Professor of Transfusion Medicine, Leiden University Medical Centre
• A van Loosbroek, Inspectorate for Health Care, The Hague
• Dr M van Marwijk Kooy, Internist/Haematologist; Isala Clinics, Zwolle
• Dr DJ van Rhenen, Professor of Transfusion Medicine; Erasmus University, Rotterdam
• Dr I Steneker, Ministry of Health, Welfare and Sport, The Hague
• Dr TJM de Witte, Professor of Haematology; Nijmegen University Medical Centre
• Dr K Groeneveld, Health Council of the Netherlands, The Hague, Secretary

Standing Committee on Immunology and Infectious Diseases

• Prof. JA Knottnerus, President of the Health Council of the Netherlands, The Hague, Chairman
• Dr M van Leeuwen, Health Council of the Netherlands, The Hague, consultant
• Dr WJHM van den Bosch, GP, Professor of General Practice; University Medical Centre Nijmegen
• Dr E Claassen, Professor of Immunology; Erasmus University, Rotterdam
• Dr RA Coutinho, Professsor of Epidemiology and the Combating of Infectious Diseases; University van Amsterdam
• Dr J Desmyter, Emeritus Professor of Virology; University of Leuven (Belgium)
• Dr JAA Hoogkamp-Korstanje, Professor of Medical Microbiology; University Medical Centre, Nijmegen
• Dr J Huisman, Emeritus Professor of Epidemiology and the Combating of Infectious Diseases; Rotterdam
• Dr CJ Lucas, Professor of Neuroimmunology; Vrije Universiteit, Amsterdam
• Dr JWM van der Meer, Professor of Internal Medicine; University Medical Centre, Nijmegen
• Dr HJ Neijens, Professor of Paediatrics; Erasmus University, Rotterdam
• Dr J van der Noordaa, Emeritus Professor of Virology; Weesp
• Dr ADME Osterhaus, Professor of Virology; Erasmus University, Rotterdam
• JL Paardekooper, Hygienist; The Hague
• Dr EJ Ruitenberg, Professor of Veterinary Immunology; University of Utrecht, Professor of International Public Health; Vrije Universiteit, Amsterdam
• Dr HA Verbrugh, Professor of Medical Microbiology; Erasmus University, Rotterdam
• JK van Wijngaarden, physician, Inspectorate for Health Care; Ministry of Health, Welfare and Sport, The Hague, consultant
• J Sekhuis, Health Council of the Netherlands, The Hague, Secretary